This study aims to construct a structuralized follow-up model for survivors of childhood hematological malignancies in China. Using a multicenter prospective cohort design, it will identify the burden and risk factors of late effects. The study hypothesizes that a standardized follow-up path managed by an electronic platform will improve follow-up compliance and reduce the missed diagnosis rate of late effects.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Incidence of severe late-effect composite endpoint.
Timeframe: From the date of enrollment to the end of follow-up (up to 36 months).
Compliance rate of the structured follow-up mode.
Timeframe: Throughout the study period (24-36 months).